Expert: Pharmacy, Medical Benefit Adoption of Biosimilars Present Different Challenges
May 2nd 2023Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.
Assessing Specialty Pharmaceutical Trends Reshaping the Field for the Future
May 11th 2022Doug Long, vice president, Industry Relations, IQVIA, discusses notable trends reshaping specialty pharmaceutical channels and the impact of these developments on the role of the pharmacist in the health care team.
Overview of Blockbuster Drugs in Oncology Approved in 2022, in the Pipeline for Approval in 2023
May 10th 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.